Tag: GSK lung cancer treatment
GSK expands deal worth $ 10.6B for lung cancer treatment
GSK plc and Nuvalent, Inc. announced that they have entered into a definitive agreement under which GSK will acquire Nuvalent, a clinical-stage biopharmaceutical company focused on...